Medical Grade Camera Articles & Analysis
2 news found
SAN DIEGO, CA – Avelas Biosciences, Inc., pioneering the field of intraoperative fluorescent cancer imaging, today announced that the company has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for pegloprastide (AVB-620) for the intraoperative detection and visualization of positive margins during breast cancer surgery. Pegloprastide is designed ...
With pegloprastide, 75% of the patients, who still had positive margins, were able to be identified. Steven Chen, M.D., Chief Medical Officer of Avelas Biosciences, said, “Today, in an era of patient-centered care, high re-excision rates need to become a historical artifact. ...